PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Association of dietary tomato intake with bladder cancer risk in a prospective cohort of 101,683 individuals with 12.5 years of follow-up. | 34244460 | Xu X, Xie B, Li S, Wang S, Xia D, Meng H | Aging (Albany NY) | 2021 | PLCO |
| Dietary phytoestrogen intake and lung cancer risk: an analysis of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. | 34370838 | Wang Q, Ru M, Zhang Y, Kurbanova T, Boffetta P | Carcinogenesis | 2021 | PLCO |
| Associations of Dietary Fat Intake With Mortality From All Causes, Cardiovascular Disease, and Cancer: A Prospective Study. | 34434952 | Yao X, Xu X, Wang S, Xia D | Front Nutr | 2021 | PLCO |
| Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts. | 33820799 | Fuhrman BJ, Moore SC, Byrne C, Makhoul I, Kitahara CM, Berrington de González A, Linet MS, Weiderpass E, Adami HO, Freedman ND, Liao LM, Matthews CE, Stolzenberg-Solomon RZ, Gaudet MM, Patel AV, Lee IM, Buring JE, Wolk A, Larsson SC, Prizment AE, Ro… | Cancer Res | 2021 | PLCO |
| Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival. | 34094683 | Du H, Liu L, Liu H, Luo S, Patz EF, Glass C, Su L, Du M, Christiani DC, Wei Q | Am J Cancer Res | 2021 | PLCO |
| Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality. | 34205398 | Bibault JE, Hancock S, Buyyounouski MK, Bagshaw H, Leppert JT, Liao JC, Xing L | Cancers (Basel) | 2021 | PLCO |
| An investigation of cross-sectional associations of a priori-selected dietary components with circulating bile acids. | 34477829 | Byrd DA, Sinha R, Weinstein SJ, Albanes D, Freedman ND, Sampson J, Loftfield E | Am J Clin Nutr | 2021 | PLCO |
| Association of genetic variants in autophagy-lysosome pathway genes with susceptibility and survival to prostate cancer. | 34500048 | Zhu Q, Meng Y, Li S, Xin J, Du M, Wang M, Cheng G | Gene | 2021 | PLCO |
| Doubly robust nonparametric instrumental variable estimators for survival outcomes. | 34676400 | Lee Y, Kennedy EH, Mitra N | Biostatistics | 2021 | PLCO |
| Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort. | 34711629 | Reichard CA, Naelitz BD, Wang Z, Jia X, Li J, Stampfer MJ, Klein EA, Hazen SL, Sharifi N | Cancer Epidemiol Biomarkers Prev | 2021 | PLCO |
| Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival. | 34692492 | Liu L, Liu H, Luo S, Patz EF, Glass C, Su L, Lin L, Christiani DC, Wei Q | Front Oncol | 2021 | PLCO |
| Ovarian Cancer Prediction from Ovarian Cysts Based on TVUS Using Machine Learning Algorithms | Akter L., Akhter N. | Proceedings of the International Conference on Big Data, IoT, and Machine Learning | 2021 | PLCO | |
| Ovarian Cancer Classification from Pathophysiological Complications using Machine Learning Techniques | L. Akter and N. Akhter | ICCCNT | 2021 | PLCO | |
| Advancing Traditional Prostate-specific Antigen Kinetics in the Detection of Prostate Cancer: A Machine Learning Model. | 34920976 | Perera M, Smith L, Thompson I, Breemer G, Papa N, Patel MI, Swindle P, Smith E | Eur Urol Focus | 2021 | PLCO |
| Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | 34906633 | King LA, Wentzensen N, Purdue MP, Katki HA, Pinto LA, Trabert B | Ann Epidemiol | 2021 | PLCO |
| High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival. | 34789471 | Brieger KK, Phung MT, Mukherjee B, Bakulski KM, Anton-Culver H, Bandera EV, Bowtell DDL, Cramer DW, DeFazio A, Doherty JA, Fereday S, Fortner RT, Gentry-Maharaj A, Goode EL, Goodman MT, Harris HR, Matsuo K, Menon U, Modugno F, Moysich KB, Qin B, Ram… | Cancer Epidemiol Biomarkers Prev | 2021 | PLCO |
| Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3). | 34652432 | Townsend MK, Trabert B, Fortner RT, Arslan AA, Buring JE, Carter BD, Giles GG, Irvin SR, Jones ME, Kaaks R, Kirsh VA, Knutsen SF, Koh WP, Lacey JV, Langseth H, Larsson SC, Lee IM, Martínez ME, Merritt MA, Milne RL, O'Brien KM, Orlich MJ, Palmer JR, … | Int J Epidemiol | 2021 | PLCO |
| Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies. | 32766851 | Lee AW, Rosenzweig S, Wiensch A, Australian Ovarian Cancer Study Group, Ramus SJ, Menon U, Gentry-Maharaj A, Ziogas A, Anton-Culver H, Whittemore AS, Sieh W, Rothstein JH, McGuire V, Wentzensen N, Bandera EV, Qin B, Terry KL, Cramer DW, Titus L, Sch… | J Natl Cancer Inst | 2021 | PLCO |
| Circulating trimethylamine N-oxide in association with diet and cardiometabolic biomarkers: an international pooled analysis. | 33826706 | Yang JJ, Shu XO, Herrington DM, Moore SC, Meyer KA, Ose J, Menni C, Palmer ND, Eliassen H, Harada S, Tzoulaki I, Zhu H, Albanes D, Wang TJ, Zheng W, Cai H, Ulrich CM, Guasch-Ferré M, Karaman I, Fornage M, Cai Q, Matthews CE, Wagenknecht LE, Elliott … | Am J Clin Nutr | 2021 | PLCO |
| Associations of circulating choline and its related metabolites with cardiometabolic biomarkers: an international pooled analysis. | 34020444 | Pan XF, Yang JJ, Shu XO, Moore SC, Palmer ND, Guasch-Ferré M, Herrington DM, Harada S, Eliassen H, Wang TJ, Gerszten RE, Albanes D, Tzoulaki I, Karaman I, Elliott P, Zhu H, Wagenknecht LE, Zheng W, Cai H, Cai Q, Matthews CE, Menni C, Meyer KA, Lipwo… | Am J Clin Nutr | 2021 | PLCO |